Arkolith/Insider Trading/RYTM/Form 4

German Christopher Paul

Corporate Controller & CAORHYTHM PHARMACEUTICALS, INC. (RYTM) · full profile →Form 4 · filed Feb 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2026Option exercise(M)4K——5K
Feb 1, 2026Tax withholding(F)1K$108.99$124K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 1, 2026Option exercise(M)2K—$04K
Feb 1, 2026Option exercise(M)2K—$05K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-009766) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML